C-Path Names Respected Business Executive to Lead its Operations Richard T. Myers, a former senior executive with engineering expertise at IBM, has been named Chief Operating Officer of the nonpr
Amgen Biomarker Toolkit – Biomarker Backgrounder Personalized Medicine: In clinical practice, personalized medicine refers to the use of new methods of molecular analysis to bette
C-Path is No. 7 in Reader’s Digest List of 18 Big Ideas to Fix Healthcare Now The November 2008 issue of Reader’s Digest lists 18 big ideas to fix healthcare now and the Critical Path Insitute is listed
FDA & EMEA to Consider Additional Test Results When Assessing New Drug Safety In the first use of a framework allowing submission of a single application to the two agencies, the Food and Drug Administration
C-Path Leads Novel Transatlantic Drug Safety Effort Companies receive go ahead from FDA and EMEA to use new improved tests when assessing safety of new drugs.
FDA Soon May Support Biomarker Tests The Food and Drug Administration is poised to throw its support behind a powerful new method of predicting the safety of experimen
US News & World Report – Genetic Tests Predict Response to Warfarin Variations of a gene that determines a person’s sensitivity to warfarin are important in determining the initial doses of th
Tucson Citizen – Blood Thinner Safety Effort Touted A Tucson-based research institute says it is improving the safety of a widely used blood thinning drug.
